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Abstract
Several  ribonucleases (RNases)  are known to  exert  a  toxic  effect  on tumor cells,  but  the
mechanism of  their  antitumor activity  is  still  poorly  understood.  The review considers  the
RNase-cell component interaction that leads to induction of apoptosis in the tumor cell. The cell
surface structures that potentially act as acceptors of exogenous RNases include acidic lipids,
glycoproteins, heparan sulfate-containing proteoglycans, actin, and RNA-associated proteins.
Normal and malignant cells differ in the membrane composition of these components, and the
difference is to a great extent responsible for the selectivity of the RNase effect. Various RNAs
may act as intracellular RNase targets, and there is evidence that exogenous RNases may
intervene in RNA interference. Potassium channels, the NF-κB signaling pathway, and various
caspases play a role in exogenous RNase-induced apoptosis. The cell sensitivity to exogenous
RNases proved to be related to expression of certain oncogenes, such as RAS, KIT, and AML1-
ETO. Understanding the mechanisms that sustain RNase cytotoxicity in susceptible malignant
cells is thought to provide a basis for designing new drugs for targeted anticancer therapy. ©
2014 Pleiades Publishing, Inc.
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